Accelerating Excellence in Translational Science (AXIS)
Project Number3U54MD007598-13S2
Former Number5U54MD007598-13
Contact PI/Project LeaderVADGAMA, JAYDUTT V.
Awardee OrganizationCHARLES R. DREW UNIVERSITY OF MED & SCI
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Despite the increasing national distribution and dissemination of COVID-19 vaccines, uptake and completion of
COVID-19 vaccine remains low among minorities. Underresourced groups, specifically minorities, are
experiencing exponentially high morbidity and mortality rates, in addition to poorer health outcomes, during the
COVID-19 pandemic. This is compounded by higher levels of vaccine hesitancy within this population, which
may be attributed to a myriad of issues, including medical mistrust and lack of access to health services. One
particular group, African American and Latinx public housing residents, are facing adverse effects related to
worsening social determinants and health disparities. Utilizing a community-driven approach, the overall
objective of this proposed study is to increase COVID-19 vaccine uptake and completion among African
American and Latinx public housing residents. Guided by the Community Based Participatory Model, the
Information, Motivation, and Behavioral Skills (IMB) and the Transtheoretical Model will be utilized to carry out
this intervention. Through this innovative program, we will establish the Academic-Community Team for
Improving Vaccine Acceptability and Targeted Engagement (ACTIVATE) program, which will develop
leadership triads of public housing resident leaders, nurse practitioner students, and public health students to
carry out this multilevel intervention. The multidisciplinary, theoretically-based, culturally-driven proposed
project is evidence-informed and promising for African American and Latinx public housing residents and will
be advanced through the following three aims: 1) To conduct a 12-week training of 30 ACTIVATE triads, who
will master information about COVID-19, and increase in knowledge and skills to address the social,
behavioral, and healthcare-related vaccination challenges among African American and Latinx public housing
residents. 2) Through the engagement and empowerment of 30 ACTIVATE triads, to jointly implement a
community-driven, culturally-sensitive plan that will a) reduce mistrust, fatalistic beliefs, and psychosocial
barriers to COVID-19 vaccine acceptance and b) increase receptivity and willingness for uptake of COVID-19
vaccine among 600 residents in public housing areas. And 3) using a pretest-posttest design, to investigate the
impact of a longitudinal, ACTIVATE-led intervention on the completion of the COVID-19 vaccine series among
252 African American and Latinx public housing residents reporting vaccine hesitancy following the Aim 2
community-level intervention. The outcomes of this proposal will produce community- and health-professional-
based vaccine leaders that can increase COVID-19 vaccine acceptance among minority public housing
residents, inducing sustainability. Overall, this study will influence evidence-based practice and inform
healthcare professionals, community groups, and policymakers on improving access and culturally-sensitive
resources for COVID-19 vaccination for these underserved populations during and after the pandemic.
Public Health Relevance Statement
PROJECT NARRATIVE
This proposal seeks to decrease vaccine hesitancy and improve acceptance of COVID-19 vaccination among
African American and Latinx public housing residents in South Los Angeles. Given the multiple COVID-19
disparities experienced by this population, we will implement a multilevel, multidisciplinary, and community-
driven intervention to engage this population in the uptake of the COVID-19 vaccination.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdverse effectsAfrican AmericanAmericasAreaBehavioralBeliefChurchCitiesCollaborationsCommunitiesCommunity HealthContractsCoronavirusDiscipline of NursingDiseaseEthnic OriginEvidence based practiceFamilyFundingHealthHealth ProfessionalHealth Services AccessibilityHealth educationHealthcareImprove AccessIndividualInterdisciplinary StudyInterventionKnowledgeLanguageLatinxLeadershipLinguisticsLos AngelesLow incomeMedicalMental disordersMinorityModelingMorbidity - disease rateMotivationMunicipalitiesNeighborhoodsNurse PractitionersOutcomeParticipantPopulationPreventiveProviderPsyche structurePublic HealthPublic Health StudentsPublic HousingRaceReportingResearchResourcesRiskSeriesStudentsTrainingTranslational ResearchTriad Acrylic ResinUnderserved PopulationUnemploymentUnited States National Institutes of HealthUniversitiesVaccinationVaccinesbasecommunecommunity based participatory researchdesigndisease transmissionempowermentexperiencehealth disparityhealth inequalitieshigh riskimprovedinnovationliteracymembermortalitymultidisciplinarypandemic diseaseprogramspsychosocialpublic educationracial and ethnicskillssocialsocial determinantstailored messaginguptakevaccine acceptancevaccine hesitancywillingness
National Institute on Minority Health and Health Disparities
CFDA Code
307
DUNS Number
785877408
UEI
PFBDNBDS57H3
Project Start Date
28-September-2009
Project End Date
28-February-2023
Budget Start Date
01-April-2021
Budget End Date
28-February-2022
Project Funding Information for 2021
Total Funding
$358,750
Direct Costs
$250,000
Indirect Costs
$108,750
Year
Funding IC
FY Total Cost by IC
2021
National Institute on Minority Health and Health Disparities
$358,750
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U54MD007598-13S2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54MD007598-13S2
Patents
No Patents information available for 3U54MD007598-13S2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54MD007598-13S2
Clinical Studies
No Clinical Studies information available for 3U54MD007598-13S2
News and More
Related News Releases
No news release information available for 3U54MD007598-13S2
History
No Historical information available for 3U54MD007598-13S2
Similar Projects
No Similar Projects information available for 3U54MD007598-13S2